PLA2G7 and ischemic stroke: Previously, clinical epidemiological studies showed that increased plasma level of Lp-PLA2 was associated with increased risk of cardiovascular events such as myocardial infarction and ischemic stroke [7-9], and Lp-PLA2 inhibitors could significantly reduce the incident of cardiovascular events as compared to placebo treatment [10,11].